Experimental techniques for developing new drugs acting on dementia (10) Alzheimer's disease animal model induced by β-amyloid protein

A. Nitta, T. Nabeshima

研究成果: Article

8 引用 (Scopus)


To develop an animal model of Alzheimer's disease, β-amyloid protein was infused into the rat cerebral ventricle for 14 days using a mini-osmotic pump. The performance of some memory tasks in the β-amyloid protein-treated rats was impaired. Long-term potentiation in the hippocampus was impaired in β-amyloid-infused rats. The impairment of memory under the infusion could be recovered by two cognitive enhancer drugs. Choline acetyltransferase activity significantly decreased in the frontal cortex and hippocampus but glial fibrillary acidic protein immunoreactivity increased in the cortex both immediately and 2 weeks after cessation of the infusion. Ciliary neurotrophic factor contents in several brain areas in β-amyloid-infused rat significantly increased. Substance P and microtubule-associated protein, which play an important role in neuronal transmission and construction of neuronal cells, respectively decreased. Moreover, the release of acetylcholine and dopamine from the cortex/hippocampus and striatum, respectively, in the β-amyloid-infused rats after depolarization was smaller than that from the control rats. These results suggest that β-amyloid protein induced dysfunction of the central nervous system in vivo, and that the animal could be used as a model of Alzheimer's disease.

ジャーナルJapanese Journal of Psychopharmacology
出版物ステータスPublished - 11-09-1996


All Science Journal Classification (ASJC) codes

  • Medicine(all)